Researchers followed 574 adults in the national Midlife in the United States study for about nine years. People who reported poor sleep quality at an average age of 52 scored lower on measures of psychological well being nearly a decade later. After accounting for age, health, education, and employment, the link held for women but not for men. The findings were presented at the SLEEP 2026 meeting and published in the journal Sleep's abstract supplement.

A 2026 review in AJMC rounds up where GLP-1 evidence now stands beyond blood sugar and the scale. The standout: in the STEP 9 trial, semaglutide cut knee osteoarthritis pain scores by about 42 points versus 28 with placebo, with less opioid use. The review also repeats a caution Bloomly readers have seen before, that up to 40 percent of the weight lost on these drugs can be lean mass, so protein targets and strength work belong in any plan.

In a randomized controlled trial published in BMC Women's Health, 38 postmenopausal women ages 45 to 65 with moderate to severe hot flashes were assigned either to a supervised 12 week program of twice weekly bodyweight strength training plus three brisk walks a week, or to usual activity. The exercise group saw a clinically meaningful drop in hot flash severity, along with better quality of life and better sleep, while the control group did not improve.

The American Cancer Society expects about 112,000 new invasive melanoma diagnoses in the United States in 2026, including roughly 46,600 in women. Rates have leveled off in younger women but keep climbing by nearly 2.8 percent a year in women 50 and older. About 90 percent of melanomas are linked to UV exposure, and when the disease is found while still localized, five year survival is better than 99 percent.

Researchers surveyed 187 competitive runners, cyclists, swimmers, and triathletes ages 40 to 60, all training at least three days and three hours a week, using a validated menopause symptom scale. Sleep problems affected 88 percent, physical and mental exhaustion 83 percent, anxiety 72 percent, weight gain 67 percent, and joint or muscle discomfort 63 percent. Among women with joint pain, nearly all said it interfered with training, and about a third of the whole group reported moderate to strong negative effects on their training overall. The authors note the survey design cannot capture everything and call for menopause specific guidance for athletic women.

Researchers followed 9,704 women ages 65 and up for a decade, measuring bone density repeatedly, in one of the largest long term studies of beverages and bone. Tea drinkers held slightly higher bone density at the hip than women who drank none, with the difference more pronounced in women with higher body weight. Moderate coffee made no measurable difference either way, but more than five cups a day was tied to lower bone density at the femoral neck, especially in women who also drank alcohol. The differences were modest, intake was self reported, and an observational study cannot prove cause and effect.

Stanford researchers analyzed 21,462 people across two long running research databases, including brains donated for autopsy. Women who had used estrogen-only hormone therapy, most of them after a hysterectomy, had about 35 percent lower odds of Alzheimer's changes such as plaques and tangles in their brain tissue, about 39 percent lower odds of a dementia diagnosis in life, and better memory scores. The finding applies only to oral estrogen taken alone, not to combined estrogen and progestin or to patches and creams, and the researchers stress this is an association, not proof of protection.

A systematic review of 33 studies mapped how menopause changes common skin and hair conditions, and the effects run in both directions. Hair loss, including female pattern hair loss and frontal fibrosing alopecia, and psoriasis tend to become more common or more severe around menopause, while acne and rosacea often improve. Eczema remains common, evidence on melasma and hidradenitis suppurativa is mixed, and the authors call for more research on how hormone therapy affects skin, plus better conversations between women and their clinicians about these changes.

Harvard's Apple Women's Health Study tracked 338 women through more than 94,000 nights of sensor measured sleep in the years before and after their final period. Six in ten women showed more time awake after falling asleep in the 18 months leading up to menopause, and the added wake time after menopause was roughly four extra minutes per eight hour night, about four times what two years of aging alone would explain. In surveys, 84 percent of participants linked their sleep changes to menopause, most often alongside hot flashes, irritability, and mental exhaustion.

University College London researchers pooled 10 studies covering more than one million women in a meta-analysis published in The Lancet Healthy Longevity. They found no evidence that menopausal hormone therapy increases or decreases dementia risk, and the result held regardless of when therapy started, how long it lasted, or which formulation was used. Experts caution that the underlying evidence is low certainty and that high quality randomized trials are still needed.

Researchers analyzed the long running SWAN study, which followed women ages 42 to 52 at seven US sites for a decade, with results in The Journal of Clinical Endocrinology and Metabolism. Women with higher insulin levels at age 47 tended to start hot flashes and night sweats earlier and to have them longer, and insulin looked like a stronger predictor than body mass index once other metabolic factors were considered. About 75 percent of women get these symptoms, which can begin two years before the final period and linger up to a decade.

A new review in JAAD Reviews examined topical estrogen formulas, such as 0.3 percent estriol and 0.01 percent estradiol creams, that are increasingly marketed for aging skin. Under the microscope estrogen does stimulate collagen, thicken the epidermis, and support skin repair, but few controlled trials show improvements women can actually see, and results vary by body site and study design. The authors also note benefits look weaker in sun damaged skin, that some hormone is absorbed through the skin, and they urge caution until larger trials are done.

A Johns Hopkins meta-analysis of 64 clinical trials, published in JAMA Internal Medicine, found GLP-1 medications worked comparably well across age, race and ethnicity, starting weight, and baseline blood sugar, with one clear exception: sex. Across trials covering roughly 20,000 patients, women lost about 11 percent of their body weight on average versus about 7 percent for men. The researchers point to possible interactions with estrogen, differences in how women's bodies process the drugs, and women's lower median body weight as likely reasons. Tirzepatide was not included because it works on an additional hormone pathway.

An analysis of nearly 67,000 postmenopausal women from the Women's Health Initiative, presented at the American Society for Nutrition's annual meeting, tracked eating patterns against heart outcomes over a median of 8.2 years. Women who most closely followed the planetary health diet, built on whole grains, vegetables, fruits, nuts, and legumes with modest amounts of fish, dairy, and meat, had a 28 percent lower risk of cardiovascular disease, along with lower risks of coronary heart disease, stroke, and heart failure. Benefits showed up even at moderate adherence, with each step closer to the pattern linked to lower risk.

Harvard researchers analyzed three long-running studies covering more than 147,000 middle-aged and older adults, 79 percent of them women, followed for up to 30 years, with results published in the British Journal of Sports Medicine. People who did 90 to 119 minutes of strength training a week had a 13 percent lower risk of dying during the study period, including 19 percent fewer cardiovascular deaths and 27 percent fewer deaths from neurological disease. Pairing strength work with aerobic exercise was linked to up to a 45 percent lower risk of dying compared with staying sedentary.

A study of more than 400 postmenopausal women, published in the journal Menopause, compared women whose menopause came from surgery to remove both ovaries with women who reached it naturally. The surgical group had significantly worse genitourinary symptoms and exam findings, including vaginal dryness, pain with sex or urination, lower sexual desire, bleeding after sex, and frequent urination. Genitourinary syndrome of menopause affects an estimated 27 to 84 percent of postmenopausal women and is routinely underdiagnosed and undertreated.

A study of nearly 20,000 women who went through natural menopause before age 48, followed for a median of about 11 years, found that social disadvantage sharply raised the odds of dying early and of developing dementia. Among 14 social factors the researchers weighed, unemployment had the strongest link to both. Cumulative disadvantage was also tied to higher cardiovascular risk, though not to cancer. The authors call for routine assessment of social circumstances as part of care for women with early menopause.

A review in Post Reproductive Health lays out why the omega-3 fats EPA and DHA matter more for women in midlife. As estrogen falls, the body becomes less efficient at making these fats from plant sources, so what you get from food counts for more. DHA makes up a large share of brain fat and supports memory and focus, higher omega-3 intake tracks with fewer depressive symptoms in perimenopause, and EPA and DHA support blood vessel function and blood pressure. Most women fall well short of the roughly 450 mg a day of combined EPA and DHA the review cites, taking in closer to half that.

Researchers tracked more than 107,000 postmenopausal women in the UK Biobank for about 15 years and found high blood pressure grew more common the earlier menopause arrived: 16.6 percent for women who reached menopause after 45, 18.8 percent for age 40 to 45, and 22.6 percent for those before 40. After accounting for more than 50 other factors, premature menopause carried about a 12 percent higher risk of high blood pressure, and the excess risk appeared years before the usual age 40 marker. The society's medical director says age at menopause should be treated as its own cardiovascular risk factor.

The condition long known as PCOS was renamed PMOS, short for polyendocrine metabolic ovarian syndrome, in May 2026, to reflect that it involves several hormone systems and reaches beyond the ovaries. It affects roughly 10 million American women. Reproductive symptoms like irregular periods ease after menopause, but androgen levels stay comparatively high and the metabolic side of the condition, including insulin resistance and higher blood pressure and cholesterol, tends to persist or worsen. Harvard notes the risk of endometrial cancer runs higher for these women, roughly one in 11 versus about one in 33 for other women.

A University of Colorado bone researcher warns that three things now overlap for many midlife women: bone loss speeds up as estrogen falls, weight loss itself costs bone even in people who exercise, and about one in five US women aged 50 to 64 have used a GLP-1 medication. She recommends a baseline bone density scan before starting a weight loss drug, prioritizing resistance training rather than cardio alone, and a frank risk conversation with your clinician, especially since roughly two thirds of users stop within a year and regained weight does not bring the lost bone back with it.

Harvard researchers followed 38,283 women in the Nurses' Health Study II across the six years before and after menopause and compared 11 eating patterns, publishing the results in JAMA Network Open. Two patterns stood out for the least weight gain and the lowest obesity risk: the Planetary Health Diet and a diet designed to keep insulin response low. Both share the same backbone, plenty of nuts, fruits, vegetables, and whole grains, with less red and processed meat, fewer potatoes, and less sodium.

An analysis in Frontiers in Medicine pooled 74 randomized trials covering about 3,570 women, nearly all postmenopausal, to map how the amount of exercise affects blood pressure. At the most effective dose, roughly 1,400 to 1,500 MET minutes a week, which works out to around five to six hours of brisk walking or a smaller amount of harder exercise, systolic pressure fell by about 7 points and diastolic by about 4. Every modality helped, from aerobic and resistance work to mind body practice, and the authors rate the certainty of the evidence as low, so the exact numbers are estimates rather than guarantees.

A new study in Menopause, the journal of The Menopause Society, assessed nearly 300 women aged 40 to 64 and found that those with type 2 diabetes or prediabetes reported more frequent and more severe menopause symptoms than women with normal blood sugar, with the clearest differences showing up after menopause. The authors suggest menopause symptom care should be built into diabetes care for midlife women rather than handled as a separate problem.

A study in the journal Neurology followed more than 12,000 adults for around 26 years and found that people who reached midlife free of high blood pressure, diabetes, and smoking developed dementia roughly 13 years later than people with all three. Women in the study lived more dementia-free years than men at every risk level, though their lifetime dementia risk was higher, about 40 percent, largely because women live longer. The study is observational, so it shows association rather than proof.

A secondary analysis of a 12-week randomized trial, published in the journal Menopause, found that when postmenopausal women replaced part of their animal protein with plant protein from foods like soybeans, beans, and grains, the swap itself tracked with weight loss, roughly one kilogram for every 16 grams of animal protein traded for 13 grams of plant protein a day, independent of calorie intake. The researchers point to methionine, an amino acid concentrated in animal foods, as a possible mechanism. Worth knowing: the study comes from the Physicians Committee for Responsible Medicine, a group that advocates plant-based eating, so the framing leans in that direction.

Researchers reviewed bone density scans from 387 postmenopausal women and found that the third who used menopausal hormone therapy had about a 69 percent lower risk of osteopenia or osteoporosis at the spine and hip than nonusers. The link held after accounting for age, time since menopause, vitamin D levels, smoking, and other health conditions. The study was retrospective, so it shows a strong association rather than proof, and the findings were presented at a conference rather than published in a journal so far.

A survey of more than 7,600 US women aged 35 and older, published in the journal Menopause, found that 34 percent were unsure whether they had entered perimenopause, and uncertainty peaked at 42 percent among women aged 40 to 44. The biggest driver was symptom confusion, cited by 56 percent, since signs like fatigue, irritability, and disrupted sleep are easy to blame on stress or a busy life. Knowledge gaps and trouble reaching informed care accounted for the rest.

A study in JAMA Oncology followed more than 86,000 adults with overweight or obesity and found that those taking GLP-1 medications had a 17 percent lower overall cancer rate than closely matched adults not on the drugs. The differences were most striking for two cancers that affect only women, with endometrial cancer rates about 25 percent lower and ovarian cancer rates about 47 percent lower. The study was observational, so it shows an association rather than proof, and researchers flagged a possible uptick in kidney cancer that needs longer follow-up.

A systematic review in the journal Life pooled 16 trials covering more than 1,000 women in their 50s and early 60s and found that practicing tai chi improved bone density at the hip and lumbar spine compared with controls. The benefits were strongest in perimenopausal women, suggesting the years around the final period may be an especially good window to start, though the authors rate the overall evidence as low to moderate certainty and call for larger trials. Sessions in the trials ran 30 to 90 minutes, practiced regularly over months.

A 2026 review in Frontiers in Human Neuroscience pulled together evidence from large long-term studies, including the Framingham Heart Study and UK Biobank, and found persistent loneliness linked with measurably worse cognitive aging, with one landmark study tying it to a 54 percent higher dementia risk over ten years. The associations appear stronger in women, and researchers point to biology after menopause, including estrogen loss and heightened inflammation, as one reason women may be more vulnerable.

Burning mouth syndrome causes burning, tingling, stabbing pain, or a metallic taste on the tongue, lips, or roof of the mouth with nothing visible to explain it. Harvard Health reports it affects about 2 percent of people, and women are up to seven times more likely than men to be diagnosed, most often during perimenopause and menopause. Researchers believe overactive pain nerves are behind it, with shifting hormones and stress as suspected contributors.

A meta-analysis of eleven trials in 414 inactive adults, nearly 70 percent of them women, found that exercise snacks, meaning bursts of activity lasting five minutes or less done at least twice a day, measurably improved cardiorespiratory fitness within 4 to 12 weeks. Stair climbing, quick strength moves, and tai chi all counted, and people stuck with it, completing 91 percent of sessions.

A randomized pilot trial published in the journal Menopause tested cognitive behavioral therapy in perimenopausal and postmenopausal women dealing with both insomnia and nighttime hot flashes. Women who received CBT saw meaningful short-term improvements in insomnia severity, hot flash interference, confidence in their own sleep, and mood. The gains faded by three months, so researchers are calling for larger trials on how to keep the benefits going.

A study of more than 3,500 women presented at The Menopause Society's annual meeting found that dry eye disease is remarkably common in midlife, affecting about 53 percent of perimenopausal women and 57 percent of postmenopausal women. Shifting hormones appear to play a role, and autoimmune disease, smoking, and contact lens use raise the risk further. Researchers are urging clinicians to start screening for it routinely.

In a Mayo Clinic study of 120 postmenopausal women with overweight or obesity taking tirzepatide, the medication in Zepbound and Mounjaro, the women who were also using menopausal hormone therapy lost about 35 percent more weight over a year or more than the women on tirzepatide alone. The study was observational, so it cannot prove the hormones caused the extra loss, and the researchers themselves note that better sleep, relief from symptoms, or healthier baseline habits could explain part of the gap.

Researchers pooled 11 randomized trials covering 747 people, most of them postmenopausal women, who ate 50 to 100 grams of prunes daily, roughly 5 to 10 prunes, for 6 to 12 months. Bone density at the lumbar spine came out slightly ahead in the prune groups, a borderline result, while hip, forearm, and whole body measurements showed no significant difference and bone turnover markers did not move. The authors call the evidence preliminary and modest, limited by small studies and short durations.

In a study that followed more than 13,000 women, average age 72, for a decade, those who reached 4,000 steps on just one or two days a week had a 27 percent lower risk of cardiovascular disease and a 26 percent lower risk of dying during the study than women who never hit that mark. Reaching 4,000 steps on three or more days a week pushed the drop in death risk to about 40 percent. What mattered most was the total amount walked over the week, not spreading it evenly across every day.

Doctors now call the cluster of joint pain, muscle aches, stiffness, and fatigue that often arrives as estrogen falls the musculoskeletal syndrome of menopause, a term coined in late 2024. Harvard Health reports it affects about 70 percent of women in perimenopause and menopause, with roughly one in four experiencing symptoms severe enough to disrupt daily life. Because estrogen receptors sit in joints, tendons, muscle, and bone, dropping levels are felt across the whole body, and unlike fibromyalgia these aches often improve with hormone therapy, strength training, regular movement, and anti-inflammatory foods.

Hair shedding while taking a GLP-1 medication is common enough that dermatologists estimate a quarter to a third of people notice some. It is not listed as a side effect of the medication, and the reason is that the drug is not what causes it. Rapid weight loss is. The body reads a fast drop in weight as stress, shifts resources away from hair, and pushes more follicles into their resting phase. The result is a diffuse shed across the whole scalp called telogen effluvium. The timing is what confuses people. Shedding usually peaks two to four months after the trigger, so by the time you notice it you have often stopped connecting it to anything. It typically resolves on its own within three to six months as the body settles, and hair regrows.

Researchers pooled 23 randomized controlled trials covering 1,474 people and concluded there is currently no clinical evidence that collagen supplements prevent or treat skin aging. The interesting part is how they got there. Pooling every trial together did show improvements in hydration, elasticity and wrinkles, but when the authors separated the studies by who paid for them, the trials without industry funding showed no benefit while the commercially backed ones reported positive results. Looking only at the higher quality studies, no significant effect appeared in any category. Supplement industry groups pushed back, arguing the analysis lumped very different collagen formulations together, misclassified some funding sources, and set aside other reviews that found a benefit.

Flavonoids are natural compounds in foods like berries, apples, citrus, and black tea. In a study that followed more than 62,000 women for 24 years, those who ate the most flavonoid-rich foods had a 15 percent lower risk of frailty, a 12 percent lower risk of declining physical function, and a 12 percent lower risk of poor mental health. Adding just three servings a day of these foods was linked to a 6 to 11 percent lower risk across all three.

In a national survey of 2,200 women, middle-aged women reported the most problematic drinking of any age group, yet they were also the least aware that alcohol raises breast cancer risk. That risk rises with the amount you drink, and for cancer prevention no amount is considered fully safe. The researchers point to caregiving stress, work and money pressure, and marketing that wraps wine into women's social lives as reasons drinking has crept up in this stage of life.

Urinary tract infections that keep coming back are a common and miserable part of life after menopause, driven by the same tissue changes that cause dryness. Low-dose vaginal estrogen treats those changes directly, and research shows it sharply cuts the odds of repeat infections, with one study linking it to lower rates of sepsis and hospitalization over the following eight years. Even so, a 2025 study found that only about 9 percent of women on Medicare with these symptoms filled a prescription for it.

Frozen shoulder happens when the capsule around the shoulder joint stiffens and contracts, and it is most common in women between 40 and 60. Researchers think falling estrogen plays a role, since estrogen naturally calms inflammation and helps keep tissue from thickening. The condition moves through three stages, from a painful freezing phase through stiffness to a slow thaw, and the full course can run from many months to two years.

Magnesium takes part in more than 300 processes in the body, from steadying blood sugar and supporting bone to easing muscle cramps, calming nerves, and helping sleep. Many women fall short without realizing it, and low levels can show up as fatigue, cramps, stiffness, or a low mood. Adult women need about 320 milligrams a day, best reached first through nuts, seeds, leafy greens, beans, and whole grains.

A fluttering, pounding, or racing heartbeat is a common and under-discussed part of perimenopause. As estrogen dips, heart rate can climb, and a single hot flash can raise it by 8 to 16 beats per minute. Up to 40 percent of women in perimenopause and about half of women after menopause notice palpitations. They are often harmless, but they can overlap with anxiety, caffeine, poor sleep, thyroid issues, or low iron, so they are worth understanding rather than brushing off.

In a study that followed more than 5,400 women aged 63 and older for eight years, those with a stronger grip and a faster sit-to-stand time lived longer. The gains were meaningful: the risk of dying dropped about 15 percent for each solid increase in grip strength and about 9 percent for a faster chair-stand time. The good news is that both are trainable at any age with regular resistance work.

The FDA approved elinzanetant, sold as Lynkuet, in October 2025 for moderate to severe hot flashes and night sweats. It is the first medicine of its kind, blocking two brain signals (the NK1 and NK3 receptors) involved in how the body controls temperature, so it works without hormones. In its main trials, women had several fewer hot flashes a day within four weeks, plus better sleep and quality of life by week 12, with few side effects reported.

Strength and balance begin declining in midlife, well before falls become a worry. A handful of simple moves, like sit-to-stands, heel raises, and standing on one leg, are proven to build the leg strength and steadiness that protect you later. No equipment is needed, and a few minutes most days is enough to start.

In a Harvard study that followed more than 5,000 older adults for nearly nine years, those who ate the most ultra-processed foods had a 58 percent higher risk of developing dementia. People who ate mostly whole, minimally processed foods showed the opposite pattern, with a 41 percent lower risk. The study cannot prove cause and effect, but it strengthens the case for trimming packaged foods.

The FDA has approved Foundayo (orforglipron), the first GLP-1 weight loss pill you can take at any time of day, with or without food. In clinical trials, people on the highest dose lost an average of 12.4 percent of their body weight. It is somewhat less potent than the injections, but it removes the needle and the strict fasting rules that come with other pills.

Migraine attacks often become more frequent and intense during perimenopause because estrogen levels swing up and down instead of holding steady. There are more options than ever, from treating attacks early with acute medicines to steady-dose hormone patches that smooth out the fluctuations. For many women, attacks ease once hormone levels settle after menopause.

Iron can run low enough to cause fatigue, brain fog, and poor exercise tolerance well before it shows up as anemia on a standard blood count. Research points to ferritin, a marker of iron stores, as the better early signal, and supplementation helped fatigue in women with low ferritin. Women with heavy or frequent periods are especially at risk.

Updated 2025 guidance from the US Preventive Services Task Force says every woman 65 and older should get a DEXA bone density scan, and younger postmenopausal women with risk factors should now get the scan too, not just a questionnaire. Bone loss speeds up around menopause and has no symptoms until a fracture happens. A quick, low-dose scan catches it early.

In a study of postmenopausal women, those who ate closer to a Mediterranean pattern, rich in vegetables, fruit, whole grains, olive oil, and fish, reported fewer and milder hot flashes and better quality of life. The same eating style is already linked to stronger heart and metabolic health in midlife. No single food is a cure, but the overall pattern appears to help.

Instead of one steady pace, you alternate three minutes of brisk walking with three minutes of easy walking, repeated for about 30 minutes. Studies on this pattern, often called the Japanese walking method, show bigger gains in heart fitness, leg strength, and blood pressure than steady walking. It is free, gentle on the joints, and works for most fitness levels.

ACOG explains that shifting hormones in perimenopause can make periods heavier, lighter, closer together, or farther apart, so changes on their own are usually not alarming. But soaking through a pad or tampon every hour, bleeding longer than a week, or any bleeding after menopause deserves a medical check. Heavy bleeding can also drain your iron and leave you exhausted.

The FDA has approved self-collection HPV tests, including the first at-home device, so women can screen for cervical cancer risk without a speculum exam. The American Cancer Society notes self-collected samples detect the virus about as accurately as clinician-collected ones, and screening guidance now includes a self-collection option for average-risk women.

A peer-reviewed review finds creatine supports muscle, bone, and possibly brain health across every stage of a woman's life, including menopause. Women naturally store less creatine than men and tend to get less from food, which may make supplementing more useful. About 3 to 5 grams daily paired with strength training showed the most benefit.

Nearly 1 in 3 women experience urinary incontinence, but it is not something you have to live with. Mayo Clinic clinicians outline a full menu of options, from pelvic floor physical therapy and simple diet changes to Botox injections, nerve stimulation, and minimally invasive procedures. Most women can find real relief without major surgery.

GoodRx's coverage tracker shows brand name GLP-1s still run well over $1,000 a month without insurance, and commercial coverage for weight loss got tighter in 2026 rather than looser. More than 16 million insured people have no coverage for any weight loss GLP-1, and most who do face prior authorization or step therapy. A new Medicare pilot and discount programs can lower costs for some, but access stays patchy.

A University of Colorado bone researcher describes a possible perfect storm for women who start GLP-1 drugs around menopause: estrogen is already declining, which speeds bone loss, and rapid weight loss can take muscle and bone along with fat. Studies suggest about a quarter of the weight lost on these medications can be lean mass. In her research, endurance cardio alone did not protect bone, so resistance training and enough protein are the stronger defense.

Endocrinologists at NewYork-Presbyterian and Weill Cornell reanalyzed data from the large SURMOUNT tirzepatide trials and found the medication produced roughly 20% weight loss in women whether they were premenopausal, perimenopausal, or postmenopausal. It also meaningfully reduced waist size, which matters because midlife weight often settles around the middle and raises heart and metabolic risk.

In late 2025 the FDA moved to remove the long-standing boxed warning about heart disease, breast cancer, and dementia from estrogen products, and to add age-specific guidance noting benefits when therapy begins within ten years of menopause. A separate warning about endometrial cancer stays on estrogen-only products.

Most women fall short of the roughly 25 to 35 grams of fiber a day that steadies blood sugar, keeps you full, and feeds a healthy gut. Soluble fiber from oats, beans, apples, and pears also helps lower LDL cholesterol, which matters more as heart risk rises after menopause.

For some postmenopausal women with distressing low sexual desire, low-dose testosterone kept within the normal female range can modestly improve desire and satisfaction. Experts are clear this is the one well-studied use, that long-term safety data are still limited, and that it is not a proven fix for energy, mood, or other symptoms.

Around half of women notice new joint aches and stiffness near menopause, and researchers now call it the musculoskeletal syndrome of menopause. As estrogen falls, inflammation rises, joints lose some lubrication, and pain sensitivity can climb. Movement, strength work, an anti-inflammatory diet, and for some women hormone therapy can all help.

For women who cannot or prefer not to take hormones, a newer class of non-hormonal medications called NK3 receptor antagonists targets the brain pathway behind hot flashes directly. Trials show large reductions in how often and how severely they strike.

Roughly 40 to 60 percent of women in perimenopause and menopause struggle with sleep, driven by night sweats, shifting hormones, and higher stress hormones. Experts point to cognitive behavioral therapy for insomnia as a proven first-line, non-drug approach.

Around two-thirds of women report memory and concentration trouble during menopause. Researchers have documented real, usually temporary shifts in brain regions tied to memory, and stress that this fog is typically mild, variable, and different from dementia.

Heart disease is the leading cause of death in women, and risk climbs after menopause. New research frames perimenopause as a window of opportunity, when catching rising cholesterol and blood sugar early can meaningfully change long-term heart health.

As estrogen falls, the body tends to store more fat around the middle while muscle loss slows metabolism. Experts note aging plays a large role too, and that strength, protein, and daily activity matter more than any single diet.

Vaginal dryness and discomfort affect many women during and after menopause, yet often go unmentioned. Guidelines point to effective, low-risk options, from moisturizers and lubricants to low-dose vaginal estrogen, that can restore comfort.

An analysis of 120 million patient records found women who began estrogen therapy in perimenopause showed no higher rates of breast cancer, heart attack, or stroke than those who started later or never.

Decades of Nurses’ Health Study data link higher midlife protein intake to healthier aging, with related trials pointing to roughly 1.2 grams per kilogram of body weight daily to preserve muscle and strength.

A meta-analysis of 17 trials found resistance training meaningfully raises bone mineral density at the spine and hip in postmenopausal women, with the strongest gains from lifting two to three times a week.

ACOG explains that shifting hormones can trigger new or worsening anxiety and low mood even with no prior history, and stresses these changes are physiological and treatable.